title: 90Y/177Lu-DOTATATE therapy: survival of the fittest?
authors.forename: Boudewijn
authors.initials: B
authors.lastname: Brans
authors.forename: Felix M
authors.initials: FM
authors.lastname: Mottaghy
authors.forename: Alfons
authors.initials: A
authors.lastname: Kessels
mesh_terms: D005260:Female; D006801:Humans; D008187:Lutetium / Q000627:therapeutic use*; D008297:Male; D018358:Neuroendocrine Tumors / Q000532:radiotherapy*; D015282:Octreotide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use*; D011868:Radioisotopes / Q000627:therapeutic use*; D011878:Radiotherapy / Q000379:methods*
chemical_list: C539274:90Y-octreotate, DOTA(0)-Tyr(3)-Thr(8)-; D009942:Organometallic Compounds; D011868:Radioisotopes; D008187:Lutetium; D015282:Octreotide